Epidemiological assessment of continuing transmission of lymphatic filariasis in Samoa

REFERENCES

• Beuria MK, Bal MS, Mandal NN, Das MK. (2003). Age-dependent prevalence of asymptomatic amicrofilaraemic individuals in a Wuchereria bancrofti-endemic region of India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 297–298.
   PubMed Web of Science ®Google Scholar
• Burkot TR, Taleo G, Toeaso V, Ichimori K. (2002). Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities. Annals of Tropical Medicine and Parasitology, 96, S61–S69.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (1993). Recommendations of the International Task Force for Disease Eradication. Morbidity and Mortality Weekly Reports Recommendations and Reports, 42, 1–38.
   PubMedGoogle Scholar
• Chandrashekar R, Curtis KC, Ramzy RM, Liftis F, Li BW, Weil GJ. (1994). Molecular cloning of Brugia malayi antigens for diagnosis of lymphatic filariasis. Molecular and Biochemical Parasitology, 64, 261–271.
   PubMed Web of Science ®Google Scholar
• Chanteau S, Glaziou P, Plichart C, Luquiaud P, Moulia-Pelat JP, N’Guyen L, Cartel JL. (1995). Wuchereria bancrofti filariasis in French Polynesia: age-specific patterns of microfilaremia, circulating antigen, and specific IgG and IgG4 responses according to transmission level. International Journal for Parasitology, 25, 81–85.
   PubMed Web of Science ®Google Scholar
• Chanteau S, Roux JF. (2008). [Bancroftian lymphatic filariasis: toward its elimination from the Pacific?]. Bulletin de la Societe de Pathologie Exotique, 101, 254–260.
   PubMedGoogle Scholar
• Clopper C, Pearson E. (2005). JavaStat: Exact Binomial and Poisson Confidence Intervals [document on the Internet]. Available at: http://statpages.org/confint.html [accessed 25 May 2009].
   Google Scholar
• Durrheim DN, Nelesone T, Speare R, Melrose W. (2003). Certifying lymphatic filariasis elimination in the Pacific — the need for new tools. Pacific Health Dialog, 10, 149–154.
   PubMedGoogle Scholar
• Dylewski JS, Rasmussen L, Mills J, Merigan TC. (1984). Large-scale serological screening for cytomegalovirus antibodies in homosexual males by enzyme-linked immunosorbent assay. Journal of Clinical Microbiology, 19, 200–203.
   PubMed Web of Science ®Google Scholar
• Esterre P, Plichart C, Sechan Y, Nguyen NL. (2001). The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Tropical Medicine and International Health, 6, 190–195.
   PubMed Web of Science ®Google Scholar
• Grady CA, de Rochars MB, Direny AN, Orelus JN, Wendt J, Radday J, Mathieu E, Roberts JM, Streit TG, Addiss DG, Lammie PJ. (2007). Endpoints for lymphatic filariasis programs. Emerging Infectious Diseases, 13, 608–610.
   PubMed Web of Science ®Google Scholar
• Hoti SL, Elango A, Radjame K, Yuvaraj J, Pani SP. (2002). Detection of day blood filarial antigens by Og4C3 ELISA test using filter paper samples. National Medical Journal of India, 15, 263–266.
   PubMed Web of Science ®Google Scholar
• Huppatz C, Capuano C, Palmer K, Kelly PM, Durrheim DN. (2009). Lessons from the Pacific Programme to Eliminate Lymphatic Filariasis: a case study of 5 countries. BMC Infectious Diseases, 9, 92.
   PubMed Web of Science ®Google Scholar
• Ichimori K. (2001). Entomology of the filariasis control programme in Samoa, Aedes polynesiensis and Ae. samoanus. Medical Entomology and Zoology, 52, 11–21.
   Google Scholar
• Ichimori K, Crump A. (2005). Pacific collaboration to eliminate lymphatic filariasis. Trends in Parasitology, 21, 441–444.
   PubMed Web of Science ®Google Scholar
• Ichimori K, Graves PM, Crump A. (2007a). Lymphatic filariasis elimination in the Pacific: PacELF replicating Japanese success. Trends in Parasitology, 23, 36–40.
   PubMed Web of Science ®Google Scholar
• Ichimori K, Tupuimalagi-Toelupe P, Toeaso Iosia V, Graves PM. (2007b). Wuchereria bancrofti filariasis control in Samoa before PacELF (Pacific Programme to Eliminate Lymphatic Filariasis). Tropical Medicine and Health, 35, 261–269.
   Google Scholar
• Joseph H, Clough A, Peteru A, Crawley S, Pulu T, Maiava F, Melrose WD. (2010). Exploratory study investigating factors influencing mass drug administration (MDA) compliance for lymphatic filariasis in Samoa. Samoa Medical Journal, 2, 12–25.
   Google Scholar
• Joseph H, Maiava F, Naseri T, Taleo F, ‘Ake M, Capuano C, Melrose WD. (2011a). Application of the Filariasis CELISA anti-filarial IgG4 antibody assay in surveillance in lymphatic filariasis elimination programmes in the South Pacific. Journal of Tropical Medicine, 2011, 492023.
   PubMedGoogle Scholar
• Joseph H, Moloney J, Maiava F, McClintock S, Lammie P, Melrose W. (2011b). First evidence of spatial clustering of lymphatic filariasis in an Aedes polynesiensis endemic area. Acta Tropica, 120, S39–S47.
   PubMed Web of Science ®Google Scholar
• Joseph HM, Melrose WD. (2010). Applicability of the filter paper technique for detection of antifilarial IgG4 antibodies using the Bm14 Filariasis CELISA. Journal of Parasitology Research, 2010, 594687.
   PubMedGoogle Scholar
• Kimura E, Penaia L, Spears GF. (1985). Epidemiology of subperiodic Bancroftian filariasis in Samoa 8 years after control by mass treatment with diethylcarbamazine. Bulletin of the World Health Organization, 63, 869–880.
   PubMed Web of Science ®Google Scholar
• Kyelem D, Biswas G, Bockarie MJ, Bradley MH, El-Setouhy M, Fischer PU, Henderson RH, Kazura JW, Lammie PJ, Njenga SM, Ottesen EA, Ramaiah KD, Richards FO, Weil GJ, Williams SA. (2008). Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. American Journal of Tropical Medicine and Hygiene, 79, 480–484.
   PubMed Web of Science ®Google Scholar
• Lammie PJ, Reiss MD, Dimock KA, Streit TG, Roberts JM, Eberhard ML. (1998). Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. American Journal of Tropical Medicine and Hygiene, 59, 217–221.
   PubMed Web of Science ®Google Scholar
• Lammie PJ, Weil G, Noordin R, Kaliraj P, Steel C, Goodman D, Lakshmikanthan VB, Ottesen E. (2004). Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis — a multicenter trial. Filaria Journal, 3, 9.
   PubMedGoogle Scholar
• Mahoney LE, Kessel JF. (1971). Treatment failure in filariasis mass treatment programmes. Bulletin of the World Health Organization, 45, 35–42.
   PubMed Web of Science ®Google Scholar
• Melrose WD, Durrheim DD, Burgess GW. (2004). Update on immunological tests for lymphatic filariasis. Trends in Parasitology 20, 255–257.
   PubMed Web of Science ®Google Scholar
• Michael E, Malecela-Lazaro MN, Maegga BT, Fischer P, Kazura JW. (2006). Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions. Trends in Parasitology, 22, 529–535.
   PubMed Web of Science ®Google Scholar
• Mladonicky JM, King JD, Liang JL, Chambers E, Pa’au M, Schmaedick MA, Burkot TR, Bradley M, Lammie PJ. (2009). Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa. American Journal of Tropical Medicine and Hygiene, 80, 769–773.
   PubMed Web of Science ®Google Scholar
• Njenga SM, Wamae CN, Mwandawiro CS, Molyneux DH. (2007). Immuno-parasitological assessment of Bancroftian filariasis in a highly endemic area along the River Sabaki, in Malindi district, Kenya. Annals of Tropical Medicine and Parasitology, 101, 161–172.
   PubMed Web of Science ®Google Scholar
• Ottesen EA. (2006). Lymphatic filariasis: treatment, control and elimination. Advances in Parasitology, 61, 395–441.
   PubMed Web of Science ®Google Scholar
• PacELF. (2006). The PacELF Way: Towards Elimination of Lymphatic Filariasis 1999–2005. Geneva: World Health Organization.
   Google Scholar
• Ramaiah KD, Thiruvengadam B, Vanamail P, Subramanian S, Gunasekaran S, Nilamani N, Das PK. (2009). Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme. Tropical Medicine and International Health, 14, 870–876.
   PubMed Web of Science ®Google Scholar
• Ramalingam S. (1968). The epidemiology of filarial transmission in Samoa and Tonga. Annals of Tropical Medicine and Parasitology, 62, 305–324.
   PubMed Web of Science ®Google Scholar
• Ramzy RM. (2002). Recent advances in molecular diagnostic techniques for human lymphatic filariasis and their use in epidemiological research. Transactions of the Royal Society of Tropical Medicine and Hygiene, 96, S225–S259.
   PubMedGoogle Scholar
• Ramzy RM, Helmy H, Faris R, Gad AM, Chandrashekar R, Weil GJ. (1995). Evaluation of a recombinant antigen-based antibody assay for diagnosis of Bancroftian filariasis in Egypt. Annals of Tropical Medicine and Parasitology, 89, 443–446.
   PubMed Web of Science ®Google Scholar
• Rawlins SC, Siung-Chang A, Baboolal S, Chadee DD. (2004). Evidence for the interruption of transmission of lymphatic filariasis among schoolchildren in Trinidad and Tobago. Transactions of the Royal Society of Tropical Medicine and Hygiene, 98, 473–477.
   PubMed Web of Science ®Google Scholar
• Sasa M. (1976). Human Filariasis: A Global Survey of Epidemiology and Control. Baltimore, MD: University Park Press.
   Google Scholar
• Supali T, Rahmah N, Djuardi Y, Sartono E, Ruckert P, Fischer P. (2004). Detection of filaria-specific IgG4 antibodies using Brugia Rapid test in individuals from an area highly endemic for Brugia timori. Acta Tropica, 90, 255–261.
   PubMed Web of Science ®Google Scholar
• Tisch DJ, Bockarie MJ, Dimber Z, Kiniboro B, Tarongka N, Hazlett FE, Kastens W, Alpers MP, Kazura JW. (2008). Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. American Journal of Tropical Medicine and Hygiene, 78, 289–293.
   PubMed Web of Science ®Google Scholar
• Tisch DJ, Hazlett FE, Kastens W, Alpers MP, Bockarie MJ, Kazura JW. (2001). Ecologic and biologic determinants of filarial antigenemia in Bancroftian filariasis in Papua New Guinea. Journal of Infectious Diseases, 184, 898–904.
   PubMed Web of Science ®Google Scholar
• Weil GJ, Curtis KC, Fischer PU, Won KY, Lammie PJ, Joseph H, Melrose WD, Brattig NW. (2010). A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14. Acta Tropica, 120, S19–S22.
   PubMed Web of Science ®Google Scholar
• Weil GJ, Kastens W, Susapu M, Laney SJ, Williams SA, King CL, Kazura JW, Bockarie MJ. (2008). The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on Bancroftian filariasis in Papua New Guinea. PLoS Neglected Tropical Diseases, 2, e344.
   PubMed Web of Science ®Google Scholar
• Weil GJ, Ramzy RM. (2007). Diagnostic tools for filariasis elimination programs. Trends in Parasitology, 23, 78–82.
   PubMed Web of Science ®Google Scholar
• Weil GJ, Ramzy RM, El Setouhy M, Kandil AM, Ahmed ES, Faris R. (1999). A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up. American Journal of Tropical Medicine and Hygiene, 61, 53–58.
   PubMed Web of Science ®Google Scholar
• WHO. (2005). Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. Report no. WHO/CDS/CPE/CEE 2005·50. Available at: http://www.searo.who.int/LinkFiles/New_Lymphatic_Filariasis_OMS_LF_ME_Assessment.pdf (accessed October 2010).
   Google Scholar
• WHO. (2007). Report of the ninth workshop for Pacific lymphatic filariasis programme managers. RS/2007/GE/20(FIJ). June 2007. Fiji. Available at: http://www.wpro.who.int/NR/rdonlyres/68DCB443-20CD-4E7E-96F5-0FB73092123C/0/MR_NinthWorkshopPacificLympFilariasisProgramme.pdf (accessed October 2010).
   Google Scholar